Detalles de la búsqueda
1.
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.
J Infect Dis
; 227(6): 761-772, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35904987
2.
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
Chron Respir Dis
; 20: 14799731231202257, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37800633
3.
A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment.
J Asthma
; 59(7): 1420-1432, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34338132
4.
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial.
Respir Res
; 22(1): 279, 2021 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34711232
5.
Long-term safety and efficacy studies of epinephrine HFA metered-dose inhaler (Primatene® Mist): a two-stage randomized controlled trial.
J Asthma
; 58(5): 633-644, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31959019
6.
Efficacy and Safety of Inhaled Glycopyrronium Bromide in COPD: A Randomized, Parallel Group, Dose-Ranging Study (GLIMMER).
COPD
; 18(2): 181-190, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33709856
7.
A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids.
Respir Res
; 21(1): 148, 2020 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32532275
8.
Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD.
Pulm Pharmacol Ther
; 60: 101873, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31841699
9.
Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis.
BMC Pulm Med
; 20(1): 134, 2020 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32393215
10.
Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective.
Respir Res
; 20(1): 141, 2019 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31286970
11.
Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study.
Respir Res
; 20(1): 167, 2019 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31358008
12.
Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD).
Respir Res
; 20(1): 241, 2019 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31666076
13.
Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial.
Respir Res
; 20(1): 238, 2019 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31666084
14.
Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study.
Eur Respir J
; 52(3)2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30220648
15.
A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD.
Respir Res
; 19(1): 38, 2018 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29506504
16.
Fluticasone furoate/vilanterol once daily improves night-time awakenings in asthma patients with night symptoms: Post hoc analyses of three randomized controlled trials.
J Asthma
; 55(8): 890-897, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28783413
17.
A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease.
Respir Res
; 18(1): 182, 2017 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29096627
18.
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res
; 18(1): 8, 2017 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28061907
19.
Randomized, dose-ranging study of a fluticasone propionate multidose dry powder inhaler in adolescents and adults with uncontrolled asthma not previously treated with inhaled corticosteroids.
J Asthma
; 54(1): 89-98, 2017 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27285965
20.
Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.
Lung
; 195(6): 739-747, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28993871